CURRICULUM VITAE
DEBRA L. BRENEMAN, M.D.
University
of Cincinnati Department of Dermatology
University
Dermatology Consultants, Inc.
222
Piedmont Avenue, Suite 5300
Cincinnati,
Ohio 45219
BOARD CERTIFICATION
Diplomate -
American Board of Dermatology - 1985
PROFESSIONAL APPOINTMENTS
Associate
Professor of Clinical Dermatology
University
of Cincinnati Medical Center
Cincinnati,
Ohio
Attending
Staff
University
of Cincinnati Medical Center
Cincinnati,
Ohio
Consulting
Staff
Veteran's
Administration Medical Center
Cincinnati,
Ohio
Consulting
Staff
Children's
Hospital Medical Center
Cincinnati,
Ohio
Consulting
Staff
The
Christ Hospital
Cincinnati,
Ohio
Consulting
Staff
The
Jewish Hospital
Cincinnati,
Ohiio
Consulting
Staff
Brown
County General Hospital
Georgetown,
Ohio
Consulting
Staff
Drake
Center, Inc.
Cincinnati,
Ohio
PUBLICATIONS
Breneman DL,
Lucky AW, Ostrow RS, Vogler C, Jenski JF: Bowenoid
papulosis of the genitalia associated with human papillomavirus DNA type 16 in an infant
with atopic dermatitis. Pediatr Dermatol
2(4):297-301, 1985.
Belz
JL, Breneman DL,
Nordlund JJ, Solinger AM: Successful
treatment of a patient with Reiter's syndrome and AIDS using etretinate. J Am Acad Dermatol 20(5):898-903, 1989.
Breneman DL,
Amornsiripanitch S, Barron DR, Peglow S, Bushong RL:
Granulomatous secondary syphilis in a patient with human immunodeficiency
virus infection. Cutis 44:377-381,
1989.
Fivenson
DP, Breneman DL: A rapidly progressive papulovesicular eruption. Arch Dermatol 125(11):569-74, 1989.
Fivenson
DP, Crump G, Scheele P, Breneman
DL: Systemic lupus erythematosus
developing in a patient with long-standing pulmonary sarcoidosis - report of a case and
review of the literature. J Rheumatol
16:1116-1119, 1989.
Breneman DL: Use of mupirocin ointment in the treatment of
secondarily infected dermatoses. J Am Acad
Dermatol 22(5):886-892, 1990.
Fivenson
DP, Breneman DL,
Wander AH: Kaposi's varicelliform eruption:
absence of ocular involvement. Arch
Dermatol 126:1037-1039, 1990.
Kalivas
J, Breneman D, Tharp M, Bruce S, Bigby M: Urticaria: Clinical efficacy of cetirizine in
comparison with hydroxyzine and placebo. J
Allergy Clin Immunol 86:1014-1018, 1990.
Kleier
RS, Breneman DL,
Boiko S: Generalized pustulation as a
manifestation of the anticonvulsant hypersensitivity syndrome. Arch Dermatol 127:1361-1364, 1991.
Robinson
MK, Parsell KW, Breneman
DL, Cruze CA: Evaluation of the
primary skin irritation and allergic contact sensitization potential of transdermal
triprolidine. Fund Appl Toxicol,
17:103-119, 1991.
Supapannachart
N, Breneman DL,
Linnemann CC: Isolation of human immunodeficiency virus from cutaneous blister fluid in
porphyria cutanea tarda. Arch Dermatol,
127:1198-1200, 1991.
Smith
EB, Breneman DL,
Griffith RF, Herbert AA, Hickman JG, Maloney JM, Millikan LE, Sulica VI, Dromgoole SH,
Sefton J, DeGryse RE, Killey FP: Double-blind
comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the
treatment of tinea pedis. J Am Acad
Dermatol, 26:125-127, 1992.
Breneman DL,
Cardone JS, Kauffman RF, Lather RM, Searle EA, Pollack VE:
Topical capsaicin for the treatment of hemodialysis-related pruritus. J Am Acad Dermatol, 26:91-94, 1992.
Breneman DL,
Like-Nartker A, Ballman EA, Pruemer JM, Blumsack RF, Davis M, Breneman JC: Topical mechlorethamine in the treatment of
mycosis fungoides - uniformity of distribution and potential for environmental
contamination. J Am Acad Dermatol,
25:1059-1064, 1992.
Breneman DL,
Davis M, Berger V, Chaney R: A double-blind
trial comparing the efficacy and safety of augmented betamethasone dipropionate lotion to
fluocinonide solution in the treatment of severe scalp psoriasis. J Dermatol Treat, 3:19-21, 1992.
Breneman DL,
Hoppenjans WB: Scurvy in an alcoholic man. Clinical Cases in Dermatology, 4(4):2-5,
1992.
Breneman DL: Bath PUVA: An effective treatment for psoriasis
without systemic side effects. Cosmetic
Dermatology 5(3):52-53, 1992.
Foss
FM, Ihde DC, Breneman
DL, Phelps RM, Fischmann AB, Schechter GR, Linnoila I, Breneman JC, Cotelingam
JD, Ghosh BC, Steinberg SM, Lynch JW, Phares
JC, Stocker JL, Bastian A, Sausville EA: Phase
II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in
advanced mycosis fungoides/Sezary syndrome. J
Clin Oncol, 10:1907-1913, 1992.
Breneman DL,
Ariano M: Successful treatment of acne
vulgaris in women with a new topical sodium sulfacetamide/sulfur lotion. Int J
Dermatol, 32:365-367, 1993.
Doebbeling
BN, Breneman DL,
Neu HC, Aly R, Yangco BG, Holley HP, Marsh RJ, Pfaller MA, McGowan JA, Scully BE, Reagan
DR, Wenzel RP: Elimination of Staphylococcus
aureus nasal carriage in health care workers: analysis of six clinical trials with calcium
mupirocin ointment. Clin Infect Dis,
17:466-474, 1993.
Breneman DL: Bath PUVA therapy for allergic contact dermatitis
of the hands and feet. Clinical Cases in
Dermatology 5:13-17, 1993.
Breneman DL: Bacterial infections of the skin and soft tissues,
and their treatment. Curr Opin Infect Dis
6:678-682, 1993.
Breneman DL,
Breneman JC: Cutaneous T-cell lymphoma
mimicking porokeratosis of Mibelli. J Am
Acad Dermatol 29:1046-1048, 1993.
Breneman DL: Treating skin infections with topical antibiotics. The Female Patient 18:65-71, 1993.
Breneman
JC, Goldschmidt H, Breneman
DL: Ionizing radiation therapy in
dermatology (CME article). J Am Acad
Dermatol 30:157-182, 1994.
Fivenson
DP, Breneman DL,
Rosen GB, Hersh CS, Cardone JS, Mutasim D: Nicotinamide
and tetracycline therapy of bullous pemphigoid. Arch
Dermatol 130:753-758, 1994.
Drake
LA, Fallon JD, Sober A, Breneman
DL, Brown RH, Chalker D, Edwards L, Funicella T, Greene SL, Kantor I, Katz HI,
Maize JC, Millikan LE, Monroe EW, Raimer SS, Schupbach CW, Smith EB: Relief of pruritus in patients with atopic
dermatitis after treatment with topical doxepin cream.
J Am Acad Dermatol 31:613-616, 1994.
Highton
A, Quell J, Breneman D, Cullen S, Goffe B,
Griffiths C, Huerter C, Kingsley D, Piacquadio D, Pincus S, Rogers R, Scher R: Calcipotriene ointment 0.005% for psoriasis: A safety and efficacy study. J Am Acad Dermatol 32:67-72, 1995.
Breneman D, Bronsky EA, Bruce S, Kalivas JT, Klein
GL, Roth HL, Tharp MD, Treger C, Soter N: Cetirizine
and astemizole in chronic idiopathic urticaria: A
double-blind, placebo-controlled comparative trial.
J Am Acad Dermatol 33:192-198, 1995.
Drake
LA, Millikan LE, Breneman
DL, Brown RH, Chalker D, Edwards L, Fallon JD, Funicella T, Greene SL, Kantor
I, Katz HI, Maize JC, Monroe EW, Raimer SS, Schupbach CW, Smith EB, Sober A: The antipruritic effect of 5% doxepin cream in
patients with eczematous dermatitis. Arch
Dermatol 131:1403-1408, 1995.
Breneman DL: Cetirizine vs. hydroxyzine and placebo in chronic
idiopathic urticaria: A comparison with
hydroxyzine and placebo. Ann Pharmacother,
30:1075-1079, 1996.
Breneman DL: Evaluation of cutaneous lymphomas. Compr Ther, 22:169-174, 1996.
Lebwohl
M, Siskin S, Epinette W, Breneman D,
Funicella T, Kalb R, Moore J: A multi-center
trial of calcipotriene ointment and halobetasol ointment compared to either agent alone
for the treatment of psoriasis. J Am Acad
Dermatol, 35:268-269, 1996.
Pariser
DM, Pariser RJ, Breneman D, Lebwohl M, Kalb
R, Moore J, Moss H, Parker C, Fiedler V: Calcipotriene
ointment applied once a day for psoriasis: A
double-blind multicenter placebo-controlled study. Arch
Dermatol 132:1527, 1996.
Wibowo
AS, Hurtubise PE, Breneman
DL, Stroop DM, Steele PE, Schumacher HR: Evaluation
of peripheral blood in patients with mycosis fungoides/Sézary syndrome. Lab Hematol 3:3-9, 1997.
Breneman DL: Mycosis fungoides, Sézary syndrome, and the other
cutaneous T-cell lymphomas: Past and present. J
Ger Dermatol 5:A11-A14, 1997.
Breneman DL,
Breneman JC: Evaluation and treatment of
patients with cutaneous T-cell lymphoma. J
Ger Dermatol 5:339-346, 1997.
Breneman
JC, Breneman DL: Use of radiotherapy in the treatment of mycosis
fungoides. J Ger Dermatol 5:358-363,
1997.
Breneman DL,
Dunlap FE, Monroe EW, Schupbach CW, Shmunes E, Phillips SB:
Doxepin cream relieves eczema-associated pruritus within 15 minutes and is
not accompanied by a risk of rebound upon discontinuation.
J Dermatol Treat 8:161-168, 1997.
Breneman DL: Advances in dermatologic therapy with
antihistamines. Curr Opin Dermatol
4:241-245, 1997.
Breneman D, Stewart D, Hevia O, Hino P, Drake L: A double-blind, multi-center clinical trial
comparing efficacy of once daily metronidazole 1% cream to vehicle in patients with
rosacea. Cutis 61:44-47, 1998.
Ploysangam
T, Breneman DL,
Mutasim DF: Cutaneous pseudolymphomas. J Am Acad Dermatol 38:877-905, 1998.
Bagel
J, Garland WT, Breneman D, Holick M,
Littlejohn TW, Crosby D, Faust H, Fivenson D, Nichols J:
Administration of DAB389IL-2 to patients with recalcitrant
psoriasis: A double-blind, phase II multicenter trial.
J Am Acad Dermatol 38:938-944, 1998.
Scher
RK, Breneman D, Rich P, Savin RC, Feingold
DS, Konnikov N, Shupack JL, Pinnell S, Levine N, Lowe NJ, Aly R, Odom RB, Greer DL, Morman
MR, Monroe AD, Tschen EH, Elewski BE, Smith EB: A
placebo-controlled, randomized, double-blind trial of once-weekly fluconazole (150 mg, 300
mg or 450 mg) in the treatment of distal subungual onychomycosis of the toenail. J Am Acad Dermatol 38:S77-S86, 1998.
Drake
L, Babel D, Stewart DM, Rich P, Ling MR, Breneman D,
Scher RK, Martin AG, Pariser DM, Pariser RJ, Ellis CN, Kang S, Katz HI, McDonald CJ,
Muglia J, Savin RC, Webster G, Elewski BE, Leyden JJ, Monroe AD, Tschen EH, Hanifin JM,
Morman MR, Shupack JL, Levine N, Lowe NJ, Bergfeld WF, Camisa C, Feingold DS, Konnikov N,
Odom RB, Aly R, Greer DL: Once-weekly
fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of
the fingernail. J Am Acad Dermatol
38:S87-S94, 1998.
Rich
P, Scher RK, Breneman D, Savin RC, Feingold
DS, Konnikov N, Shupack JL, Pinnell S, Levine N, Lowe NJ, Aly R, Odom RB, Greer DL, Morman
MR, Monroe AD, Tschen EH, Elewski BE, Smith EB, Hilbert J:
Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, 450
mg) in distal subungual onychomycosis of the toenail.
J Am Acad Dermatol 38:S103-S109, 1998.
Savin
RC, Drake L, Babel D, Stewart DM, Rich P, Ling MR, Breneman
D, Scher RK, Martin AG, Pariser DM, Pariser RJ, Ellis CN, Kang S, Friedman
D, Katz HI, McDonald CJ, Muglia J, Webster G, Elewski BE, Leyden JJ, Monroe AD, Tschen EH,
Hanifin JM, Morman MR, Shupack JL, Levine N, Lowe NJ, Bergfeld WF, Camisa C, Feingold DS,
Konnikov N, Odom RB, Aly R, Greer DL, Hilbert J: Pharmacokinetics
of three once-weekly dosages of fluconazole (150 mg, 300 mg, or 450 mg) in distal
subungual onychomycosis of the fingernail. J
Am Acad Dermatol 38:S110-S116, 1998.
Lebwohl
MG, Breneman DL,
Goffe BS, Grossman JR, Ling MR, Milbauer J, Pincus SH, Sibbald RG, Swinyer LJ, Weinstein
GD, Lew-Kaya DA, Lue JC, Gibson JR, Sefton J: Tazarotene
0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis. J Am Acad Dermatol 39:590-596, 1998.
Koo
J, Cuffie CA, Tanner DJ, Bressinck R, Cornell RC, DeVillez RL, Edwards IE, Breneman DL,
Piacquadio DJ, Guzzo CA, Monroe EW. Mometasone
furoate 0.1%/salicylic acid 5% ointment versus mometasone furoate 0.1% ointment in the
treatment of moderate to severe psoriasis: A multicenter study. Clin Ther 20:283-291, 1998.
DeVillez
RL, Sher AM, Breneman
DL, Espy PD, Garcia CJ, Monroe EW, Tanner DJ, Cuffie CA: Comparison of the efficacy and safety of
mometasone furoate ointment 0.1% once daily and fluticasone propionate ointment 0.005%
twice daily in the management of psoriasis. Adv
Ther 15:92-97, 1998.
Breneman DL,
Berge CA, Keswick BH, Neumann PB: Evaluation
of the effect of an antibacterial bar soap with 1.5% TCC on the clinical improvement and
microbial skin flora in patients with atopic dermatitis.
Cutis in press.
Hanifine
JM, Ling MR, Sober AJ, Breneman D, Rafal E: Tacrolimus ointment for the treatment of atopic
dermatitis in adult patients: Part I, efficacy. J Am Acad Dermatol in press.
Soter
N, Fleischer A, Webster GF, Monroe E, Lawrence I, Appell N, Breneman
D, Chambers M, et al: Tacrolimus
ointment for the treatment of atopic dermatitis in adult patients: Part II, safety. J Am Acad Dermatol in press.
Adamick
C, Breneman D: Leukemia cutis. Arch Dermatol in press.
Drake
L, Prendergast M, Maher R, Breneman D,
Cooper K, Beusterien KM, Lawrence I: The
impact of tacrolimus ointment on health-related quality-of-life of adult and pediatric
patients with atopic dermatitis. J Am
Acad Dermatol, in press.
ABSTRACTS
Breneman DL,
Cardone JS, Kauffman RF, Lather RM: Topical
capsaicin for treatment of pruritus related to hemodialysis. Clin Pharmacol Ther
45(2):188, 1989.
Foss
F, Fischmann A, Schechter G, Ihde D, Breneman D,
Breneman J, Anderson M, Eddy J, Sausville E: Phase
II trial of pentostatin and interferon-alpha-2A in advanced mycosis fungoides/Sezary
syndrome. Proc Am Soc Clin Oncol
8:276, 1989.
Steele
P, Breneman DL,
Breneman JC, Barron D, Swerdlow SH: Genotypic
analysis of lymph nodes in cutaneous T cell lymphomas: Comparison with histologic
"LN" grading. Lab Invest
62:95a, 1990.
Foss
F, Fischmann A, Schechter G, Ihde D, Breneman D,
Breneman J, Sausville E: Phase II trial of
human interferon-alpha-2A and pentostatin in advanced stage mycosis fungoides/Sezary
syndrome. Proc Am Soc Clin Oncol
9:259, 1990.
Thomason
JL, Gelbart SM, Scaglione JN, James JA, Breneman DL, Leong F, Broekhuizen FF: Does cefmatazole compare to cefoxitin or
penicillin for treatment of gonorrhea? Proc
Intersci Conf Antimicrob Agent Chemother 30:251, 1990.
Breneman DL: Topical corticosteroid therapy for severe scalp
psoriasis. Clin Pharmacol Ther
51(2):128, 1992.
Breneman D, Bergstresser P, Boggs P, Bronsky E,
Bruce S, Grossman J, Kalivas J, Klein G, Roth H, Sotor N, Tharp M, Treger C: A multi-site comparative study of the efficacy and
safety of cetirizine vs. astemizole and placebo in the treatment of chronic idiopathic
urticaria. J All Clin Immunol
89(1):249, 1992.
Drake
L, Breneman D, Greene S, Raimer S, Shupbach
CW, Halperin M: Effects of topical doxepin 5%
cream on pruritic eczema. J Invest
Dermatol 98(4): 605, 1992.
Sorensen
SM, Barron DR, Breneman
DL, Breneman JC, Swerdlow SH: Paraffin
section immunohistologic evaluation of cutaneous T-cell lymphomas: The role of OPD4. Lab Invest 66:88A, 1992.
Breneman DL,
Like-Nartker A, Ballman EA, Pruemer JM, Blumsack RF, Davis M, Breneman JC: Topical mechlorethamine in the treatment of
mycosis fungoides - uniformity of application and potential for environmental
contamination. 18th World Congress of
Dermatology: Progress and Perspectives 18:29A, 1992.
Breneman DL,
Breneman JC, Wachendorf TJ, Rindler JM, Ballman EA:
Hair and nail changes following total skin irradiation. 18th World Congress of Dermatology: Progress
and Perspectives 18:29A, 1992.
Breneman DL,
Breneman JC, Swerdlow SH, Ballman EA, Steele PE, Foss FM:
Sezary syndrome: Long-term remission following topical corticosteroid
therapy. 18th World Congress of
Dermatology: Progress and Perspectives 18:29A, 1992.
Breneman DL,
Cardone JS, Blumsack RF, Lather RM, Searle EA: Topical
capsaicin for treatment of hemodialysis-related pruritus.
18th World Congress of Dermatology: Progress and Perspectives 18:29A,
1992.
Breneman DL,
Swerdlow SH, Jacobs BS, Cline DJ, Barron DR, Ballman EA, Steele PE, Breneman JC: Concurrent lymphomatoid papulosis and mycosis
fungoides. 18th World Congress of
Dermatology: Progress and Perspectives 18:30A, 1992.
Breneman DL,
Swerdlow SH, Breneman JC, Ballman EA, Kuhlman DS, Steele PE: Concurrent Ki-1 lymphoma, lymphomatoid papulosis,
and mycosis fungoides. 18th World
Congress of Dermatology: Progress and Perspectives 18:30A, 1992.
Mutasim
DF, Breneman DL,
Lorton C, Anhalt GJ: Paraneoplastic
pemphigus: Autopsy findings. 18th World Congress of Dermatology: Progress and
Perspectives 18:162A, 1992.
Rosen
GB, Fivenson DP, Breneman
DL, Hersch CS, Cardone JS, Mutasim D: Nicotinamide
and tetracycline treatment of autoimmune bullous disorders.
18th World Congress of Dermatology: Progress and Perspectives
18:194A, 1992.
Doebbeling
B, Breneman D, Marsh R, Reagan D, Wenzel R: Multi-center study of elimination of
Staphylococcus aureus nasal carriage with calcium mupirocin ointment in healthy subjects. Proc Intersci Conf Antimicrob Agent Chemother
32:392, 1992.
Hebert
AA, Breneman DL,
Grier CE, McCree LC: Comparison of topical
mupirocin ointment and oral cephalexin in the treatment of secondarily infected skin
ulcers. Proc Intersci Conf Antimicrob
Agent Chemother 32:392, 1992.
Breneman DL: The efficacy of cetirizine compared to terfenadine
and astemizole in the treatment of chronic urticaria.
Proc European Acad Dermatol Venereol 3:107, 1993.
Breneman DL,
Ariano MC, Evans C, Davis MJ, Rumsfield JA, West DP:
Adult female acne treatment with a new topical sodium sulfacetamide/sulfur
lotion. Pharmacotherapy 13:268,
1993.
Breneman DL,
Like-Nartker A, Ballman EA, Pruemer JM, Blumsack RF, Davis M, Breneman JC: Topical mechlorethamine in the treatment of
mycosis fungoides - uniformity of application and potential for environmental
contamination. In The 1993 Year Book of
Dermatology, AJ Sober, TB Fitzpatrick,
eds. Mosby-Year Book, Inc., St. Louis, 1993,
pp. 365-366.
Breneman DL,
Cardone JS, Blumsack, RF, Lather RM, Searle EA: Topical
capsaicin for treatment of hemodialysis-related pruritus.
In The 1993 Year Book of Dermatology, AJ Sober, TB Fitzpatrick,
eds. Mosby-Year Book, Inc., St. Louis, 1993, pp. 172-173.
Childress
L, Utz G, Cualing H, Debowsky T, Breneman D,
Breneman J, Steele P: BCL-2 oncoprotein
distinguishes benign from malignant in cutaneous lymphoid lesion biopsies. Modern Pathol 7:105A, 1994.
Wibowo
A, Mikhael A, Stroop DM, Hill J, Reisinger J, Breneman D,
Hurtubise P, Steele P, Yochman L, Schumacher HR: Sézary
cell expression in mycosis fungoides. Blood
84:598A, 1994.
Pincus
S, Oseroff A, Breneman D, Foss F, Koh H,
Duvic M, Vonderheid EC, Coe B, Phillips SB, Bernstein JE:
Effectiveness of topical naloxone, an opioid antagonist, in the treatment of
pruritus associated with mycosis fungoides and Sézary syndrome. J Invest Dermatol 104:661, 1995.
Berberian
BJ, Sulica VI, Breneman
DL, Drake LA, Gratton D, Raimer SS, Bernstein JE, Halperin M: Effects of adding topical doxepin to topical
corticosteroid therapy in atopic dermatitis. J
Invest Dermatol 104:691, 1995.
Breneman D, Bronsky EA, Bruce S, Valivas JT, Klein
GL, Roth HL, Thorp MD, Treger C, Soter N: Cetirizine
and astemizole in chronic idiopathic urticaria: A double-blind, placebo-controlled
comparative trial. In The 1996 Year Book of Dermatology, AJ Sober, TB
Fitzpatrick, eds. Mosby-Year Book, Inc., St.
Louis, 1996, pp. 459-461.
Breneman DL,
Duvic M, Kuzel T, Stevens V, Yocum R: Phase
1-2 clinical trial supports the safety and efficacy of Targretin topical gel, a novel
RXR-selective retinoid analogue, in the treatment of cutaneous T-cell lymphoma. J Am Soc Hematol 88:569a, 1996.
LETTERS TO EDITOR
Breneman DL,
Breneman JC: Topical mechlorethamine in the
treatment of mycosis fungoides. J Am Acad
Dermatol 27(5):786-787, 1992.
Breneman
J, Breneman D: Total skin irradiation for mycosis fungoides
associated with lymphomatoid papulosis. Int
J Rad Oncol, Biol, Phys 32:274, 1995.
CHAPTERS
Nordlund
JJ, Breneman DL,
Pelc NJ, King AD: Melanoma, Kaposi's sarcoma,
and mycosis fungoides. In Stein's Internal Medicine, fourth
edition, JH Stein, JJ Hutton, et al, eds. Mosby-Year Book, Inc., St. Louis, 1993, pp.
919-924.
Breneman DL: Advances in dermatologic therapy with
antihistamines. In Current Opinion in
Dermatology, volume 4, MV Dahl, ed. Rapid Science Publishers, Philadelphia,
Pennsylvania, 1997, pp 241-245.
Breneman DL: Cutaneous T-cell lymphoma. In The Pigmentary System. Its Physiology and
Pathophysiology, JJ Nordlund, RE Boissy, VJ Hearing, RA King, JP Ortonne, eds. Oxford University Press, New York, New York, 1998,
pp 878-883.
Breneman DL,
Van Horn JA, Breneman JC: Costs of evaluating
and treating patients with cutaneous T-cell lymphoma.
In Care Management of Skin Diseases: Life Quality and Economic Impact,
R Rajagopalan, EF Sherertz, RT Anderson, eds. Marcel
Dekker Inc., New York, New York, 1998, pp 355-367.
GUEST EDITOR
Journal
of Geriatric Dermatology: Special issue on cutaneous T-cell lymphoma. Volume 5, 1997.
PARTICIPATION IN PROFESSIONAL MEETINGS
Presentations
at International Meetings
Breneman DL,
Breneman JC, Wachendorf TJ, Rindler JM, Ballman EA:
Hair and nail changes following total skin irradiation. 18th World Congress of Dermatology, New York, New
York 6/15/92.
Breneman DL,
Cardone JS, Blumsack RF, Lather RM, Searle EA: Topical
capsaicin for treatment of hemodialysis-related pruritus.
18th World Congress of Dermatology, New York, New York 6/15/92.
Breneman DL,
Swerdlow SH, Jacobs BS, Cline DJ, Barron DR, Ballman EA, Steele PE, Breneman JC: Concurrent lymphomatoid papulosis and mycosis
fungoides. 18th World Congress of
Dermatology, New York, New York 6/16/92.
Breneman DL,
Breneman JC, Swerdlow SH, Ballman EA, Steele PE, Foss FM:
Sezary syndrome: Long-term remission following topical corticosteroid
therapy. 18th World Congress of Dermatology,
New York, New York 6/16/92.
Kalivas
J, Breneman D, Bergstresser P, Boggs P,
Bronksy E, Bruce S, Grossman J, Klein G, Roth H, Tharp M, Treger C, deMahieu C: A multi-site comparative study of the efficacy
and safety of cetirizine vs. astemizole and placebo in the treatment of chronic idiopathic
urticaria. First Asian Pacific Congress of
Allergology and Immunology, Bangkok, Thailand 11/23/92.
Breneman DL: The efficacy of cetirizine as compared to
terfenadine and astemizole in the treatment of chronic urticaria. Third Congress of the European Academy of
Dermatology and Venereology, Copenhagen, Denmark 9/28/93.
Breneman DL: Cutaneous T-cell lymphomas other than mycosis
fungoides. Second International Symposium on
Cutaneous T-Cell Lymphomas, Chicago, Illinois 10/16/93.
Breneman DL: Cost issues in the treatment of cutaneous T-cell
lymphoma. International Consensus Conference
on Staging and Treatment Recommendations for Cutaneous T-Cell Lymphoma, Cambridge,
Massachusetts 10/1/94.
Breneman DL: Newer therapeutic modalities for acne. Symposium on the Use of Tazarotene in Dermatology,
Niagra on the Lake, Canada 5/3/97.
Breneman DL,
Berge CA, Keswick BH, Neumann PB: Evaluation
of the effect of an antibacterial bar soap with 1.5% TCC on the clinical improvement and
microbial skin flora in patients with atopic dermatitis.
Venezuelan Dermatology Congress / First Venezuelan-Columbian Dermatology
Congress, Caracas, Venezuela 11/12/97.
Breneman D, Berge C, Keswick B, Neumann P,
Volkovynsky K: Evaluation of the effect of
an antibacterial soap with 1.5% triclocarbon on the clinical improvement and microbial
skin flora in patients with atopic dermatitis. Ukranian
Congress of Dermatologists, Ukraine, 9/9/99.
Presentations
at International Meetings - Discussion Sessions
Blanco
R, Miller MA, Bridges A, Steele P, Breneman D,
Zaknoen S: Peripheral T-cell lymphoma. European Association for Haematopathology IX
meeting, Leiden, The Netherlands, 4/27/98.
Duvic
M, Breneman D, Kuzel T, Straus D, Stevens V,
Yocum R: LGD1069, a novel RXR selective
retinoid analogue in the treatment of cutaneous T-cell lymphoma. European Society for Dermatologic Research in
Cutaneous Lymphomas, Berlin, Germany, 9/28/98.
International
Exhibits
Breneman DL,
Swerdlow SH, Breneman JC, Ballman EA, Kuhlman DS, Steele PE: Concurrent Ki-1 lymphoma, lymphomatoid papulosis,
and mycosis fungoides. 18th World Congress of
Dermatology, New York, New York 6/15/92.
Breneman DL,
Like-Nartker A, Ballman EA, Pruemer JM, Blumsack RF, Davis M, Breneman JC: Topical mechlorethamine in the treatment of
mycosis fungoides - uniformity of application and potential for environmental
contamination. 18th World Congress of
Dermatology, New York, New York 6/16/92.
Rosen
GB, Fivenson DP, Breneman
DL, Hersch CS, Cardone JS, Mutasim D: Nicotinamide and tetracycline treatment
of autoimmune bullous disorders. 18th World
Congress of Dermatology, New York, New York 6/16/92.
Childress
L, Utz G, Cualing H, Debowsky T, Breneman D,
Breneman J, Steele P: BCL-2 oncoprotein
distinguishes benign from malignant in cutaneous lymphoid lesion biopsies. International Academy of Pathologists 1994 annual
meeting, San Francisco, California 3/13-14/94.
Duvic
M, Breneman D, Kuzel T, Straus D, Stevens V,
Yocum R: LGD1069, a novel RXR-selective
retinoid analogue, in the treatment of cutaneous T-cell lymphoma. International Society for Cutaneous Lymphomas,
Sydney, Australia 6/14/97.
Cualing
H, Penmetsa U, Steele P, Nussbaum M, Breneman D: LN grading for staging of mycosis fungoides may
benefit from examination of multiple excised lymph nodes.
Pan-Pacific Lymphoma Conference, Lanai, Hawaii 7/15-18/97
Presentations
at National Meetings
Breneman DL: Secondary skin infections and topical therapy
considerations. Focus on Dermatological
Infections: Clinical Advances - A National Symposium; sponsored by University of
Pennsylvania School of Medicine, Williamsburg, Virginia 3/13/88.
Breneman DL: A randomized, double-blind, vehicle-controlled
evaluation of mupirocin for the treatment of secondarily infected dermatoses. American Academy of Dermatology 1988 summer
session, New York, New York 6/16/88.
Breneman DL,
Kauffman RF, Cardone JS, Lather RM: Topical
capsaicin for treatment of pruritus related to hemodialysis. American Society for Clinical Pharmacology and
Therapeutics annual meeting, Nashville, Tennessee 3/10/89.
Breneman DL: Bath PUVA: Practical use for a variety of
dermatoses. American Academy of Dermatology
1989 annual meeting, San Francisco, California 12/5/89.
Steele
P, Breneman DL,
Breneman JC, Barron DR, Swerdlow SH: Genotypic
analysis of lymph nodes in cutaneous T cell lymphomas: Comparison with histologic
"LN" grading. United States and
Canadian Academy of Pathology annual meeting, Boston, Massachusetts 3/5/90.
Cardone
JS, Breneman DL: Topical capsaicin for the treatment of
hemodialysis-related pruritus. American
Academy of Dermatology 1990 annual meeting, Atlanta, Georgia 12/3/90.
Fivenson
DP, Breneman DL,
Cardone JS, Hersh C, Rosen G, Mutasim DF: Nicotinamide
and tetracycline therapy of auto-immune bullous disorders.
American Academy of Dermatology 1991 summer session, Monterey, California,
6/13/91.
Breneman DL: Bath PUVA: Practical use for a variety of
dermatoses. American Academy of Dermatology
1991 annual meeting, Dallas, Texas 12/10/91.
Breneman DL,
Bergstresser P, Boggs P, Bronksy E, Bruce S, Grossman J, Kalivas J, Klein G, Roth H, Tharp
M, Treger C: A Multi-site comparative study
of the efficacy and safety of cetirizine vs. astemizole and placebo in the treatment of
chronic idiopathic urticaria. American
Academy of Allergy and Immunology 48th annual meeting, Orlando, Florida 3/9/92.
Breneman DL: Cutaneous lymphomas - evaluation and staging. American Academy of Dermatology 1993 summer
session, Toronto, Canada 7/16/93.
Breneman DL: Cutaneous lymphomas - evaluation and staging. American Academy of Dermatology 1993 annual
meeting, Washington, D.C. 12/8/93.
Breneman DL: Therapeutic challenge: Cutaneous T-cell lymphoma. American Academy of Dermatology 1993 annual
meeting, Washington, D.C. 12/9/93.
Breneman DL: Help, help, I'm itching and I can't stop! American College of Allergy, Asthma, and
Immunology annual meeting, Dallas, Texas 11/12/95.
Breneman DL: Evaluation of cutaneous lymphomas. American Academy of Dermatology 1996 annual
meeting, Washington, D.C. 2/13/96.
Breneman DL: Topical anti-pruritic update. American Academy of Dermatology 1996 annual
meeting, Washington, D.C. 2/14/96.
Breneman DL: Chronic urticaria: How can you make a difference
in your patient's condition? American Academy
of Physician Assistants annual meeting. New
York, New York 5/28/96.
Breneman DL: Clinical treatment applications of tazarotene:
acne vs. psoriasis. Tazarotene Clinical
Update meeting, New York, New York 9/28/96.
Breneman DL: Evaluation of cutaneous lymphomas. American Academy of Dermatology annual meeting,
San Francisco, California 3/21/97.
Breneman DL,
Duvic M, Kuzel T, Stevens V, Yocum R: Phase
1-2 clinical trial supports the safety and efficacy of Targretin topical gel, a novel
RXR-selective retinoid analogue, in the treatment of cutaneous T-cell lymphoma. American Academy of Dermatology annual meeting,
San Francisco, California 3/22/97.
Maibach
H, Breneman D, Tschen E, Reyes J, Jones T,
DeVillez R: Butenafine HCl 1% / betamethasone
dipropionate 0.05% cream in the one-week treatment of tinea pedis. Skin Disease Education Foundation annual meeting,
Santa Fe, New Mexico 10/16/97.
Breneman DL: Cutaneous T-cell lymphomas: Patient support groups
and the internet. American Academy of
Dermatology annual meeting, Orlando, Florida 2/28/98.
Breneman DL: Evaluation of cutaneous lymphomas. American Academy of Dermatology annual meeting,
Orlando, Florida 2/28/98.
Breneman DL: American Academy of Dermatology re-certification
course: Update on cutaneous T-cell lymphoma. American
Academy of Dermatology annual meeting, New Orleans, Louisiana 3/20/99.
Breneman DL: Cutaneous T-cell lymphomas: Patient support groups
and the internet. American Academy of
Dermatology annual meeting, New Orleans, Louisiana 3/20/99.
Breneman DL: Evaluation of cutaneous lymphomas. American
Academy of Dermatology annual meeting, New Orleans, Louisiana 3/20/99.
Presentations
at National Meetings - Gross and Microscopic Symposia
Breneman DL,
Estes SA: Perforating folliculitis associated
with vitamin A deficiency secondary to gastrointestinal malabsorption. American Academy of Dermatology 1984 annual
meeting, Chicago, Illinois 12/84.
Orme
RL, Breneman DL: Coexistent variegate porphyria and porphyria
cutanea tarda. American Academy of
Dermatology 1987 annual meeting, San Antonio, Texas 12/5/87.
Fivenson
DP, Breneman DL: Systemic lupus erythematosus and pulmonary
sarcoidosis. American Academy of Dermatology
1987 annual meeting, San Antonio, Texas 12/6/87.
Fu
JL, Cline DJ, Breneman
DL: Panniculitis associated with
alpha1-antitrypsin deficiency. American
Academy of Dermatology 1988 annual meeting, Washington, D.C. 12/4/88.
Supapannachart
N, Breneman DL: First isolation of human immunodeficiency virus in
cutaneous blister fluid. American Academy of
Dermatology 1991 annual meeting, Dallas, Texas 12/7/91.
Sheth
P, Breneman D, Swerdlow S, Croen K, Mutasim
D, Steele P, Whittington C, Ballman E: Granuloma
formation in two patients with adult T-cell leukemia/lymphoma in sites of previous herpes
zoster. American Academy of Dermatology 1992
annual meeting, San Francisco, California 12/6/92.
Hill
S, Rosner S, Breneman D: Mycosis fungoides masquerading as pigmented
purpuric dermatosis. American Academy of
Dermatology 1996 annual meeting 2/10/96.
Lamerson
C, Gloster H, Hoppenjans W, Mutasim D, Breneman D: Subcutaneous T-cell lymphoma with associated
hemophagocytic syndrome mimicking pyoderma gangrenosum.
American Academy of Dermatology 1997 annual meeting, San Francisco,
California 3/22/97.
Bridges
AG, Neltner S, Breneman D: Explosive peripheral T-cell lymphoma in a
teenager. American Academy of Dermatology
1997 annual meeting, San Francisco, California 3/22/97.
Adamick
C, Breneman D: Fulminant acute myelogenous
leukemia presenting in the skin. American
Academy of Dermatology annual meeting, New Orleans, Louisiana 3/20/99.
Breneman DL,
Hakim MD: Comparative cost analysis of PUVA
and methotrexate in the treatment of psoriasis. American
Academy of Dermatology annual meeting, Orlando, Florida 2/28/98.
Breneman DL,
Storer T, Breneman JC, Mutasim DF: Methotrexate-induced
cutaneous ulceration in patients with mycosis fungoides.
American Academy of Dermatology annual meeting, Orlando, Florida 3/1/98.
Breneman DL,
Raju US, Breneman JC, Steele PE, Swerdlow SH, Cualing HD:
LN grading for staging of mycosis fungoides may benefit from examination of
multiple excised lymph nodes. American
Academy of Dermatology annual meeting, Orlando, Florida 3/1/98.
Breneman D, Stewart D, Hevia E, Hino P, Drake L: A clinical efficacy trial of 1% metronidazole
cream administered once daily in the treatment of rosacea.
American Academy of Dermatology annual meeting, Orlando, Florida 3/3/98.
Breneman DL,
Van Horn JA, Breneman JC: Cutaneous T-cell
lymphoma and patient support groups. American
Academy of Dermatology annual meeting, New Orleans, Louisiana 3/21/99.
National
Exhibits
Kalivas
JT, Breneman DL,
Tharp M: Cetirizine, a novel antihistamine
for the treatment of chronic idiopathic urticaria. American
Academy of Dermatology 1988 annual meeting, Washington, D.C. 12/4-7/88. Bronze award for original scientific
investigation.
Foss
F, Fischmann A, Schechter G, Ihde D, Breneman D,
Breneman J, Sausville E: Phase II trial of
human interferon-alfa-2A and pentostatin in advanced stage mycosis fungoides/Sezary
syndrome. American Society for Clinical
Oncology 1990 annual meeting, Washington, D.C. 5/20-22/90.
Thomason
JL, Gelbart SM, Scaglione JN, James JA, Breneman DL, Leong F, Broekhuizen FF: Does cefmetazole compare to cefoxitin or
penicillin for treatment of gonorrhea? Results
of the multicenter study. Interscience
Conference on Antimicrobial Agents and Chemotherapy, Atlanta, Georgia 10/21-24/90.
Breneman DL,
Dromgoole SH, Foote P, Griffith RF, Herbert AA, Hickman JG, Maloney JM, Millikan LE,
Reeves LL, Sefton J, Smith EB, Sulica VI: Naftifine
cream compared with clotrimazole/betamethasone dipropionate cream in the treatment of
tinea pedis. American Academy of Dermatology
1990 annual meeting, Atlanta, Georgia 12/2-5/90.
Breneman DL: Topical corticosteroid therapy for severe scalp
psoriasis. American Society for Clinical
Pharmacology and Therapeutics annual meeting, Orlando, Florida 3/18/92.
Sorenson
SM, Barron DR, Breneman
DL, Breneman JC, Swerdlow SH: Paraffin
section immunohistologic evaluation of cutaneous T-cell lymphomas: The role of OPD4. United States and Canadian Academy of Pathology
annual meeting, Atlanta, Georgia 3/17/92.
Drake
L, Breneman D, Greene S, Raimer S, Shupbach,
CW, Halperin M: Effects of topical doxepin 5%
cream on pruritic eczema. Society for
Investigative Dermatology 1992 annual meeting, Baltimore, Maryland 4/30/92.
Doebbeling
B, Breneman D, Marsh R, Reagan D, Wenzel R: Multi-center study of elimination of
Staphylococcus aureus nasal carriage with calcium mupirocin ointment in healthy subjects. Interscience Conference on Antimicrobial Agents
and Chemotherapy, Anaheim, California 10/14/92.
Hebert
AA, Breneman DL,
Grier CE, McCree LC: Comparison of topical
mupirocin ointment and oral cephalexin in the treatment of secondarily infected skin
ulcers. Interscience Conference on
Antimicrobial Agents and Chemotherapy, Anaheim, California
10/14/92.
Breneman DL,
Cooper CH, Swerdlow SH, Steele PE, Ballman EA, Cline DJ, Breneman JC: Concurrent lymphomatoid papulosis and mycosis
fungoides. American Academy of Dermatology
1992 annual meeting, San Francisco, California 12/5-9/92.
Breneman DL,
Ariano MC, Evans C, Davis MJ, Rumsfield JA, West DP:
Adult female acne treatment with a new topical sodium sulfacetamide/sulfur
lotion. American College of Clinical Pharmacy
1993 annual meeting, Reno, Nevada 8/15-18/93.
Breneman DL,
Chetty VB: A multi-site comparative study of
the efficacy and safety of cetirizine vs. astemizole and placebo in the treatment of
chronic idiopathic urticaria. 98th Annual
Convention and Scientific Seminar of the American Osteopathic Association, Boston,
Massachusetts 10/10-13/93.
Tyring
S, Nahlik J, Cunningham A, Marley J, Heng M, Rea T, Breneman
D, et al: Efficacy and safety
of famciclovir in the treatment of patients with herpes zoster: Results of the first placebo-controlled study. Interscience Conference on Antimicrobial Agents
and Chemotherapy, New Orleans, Louisiana 10/17-20/93.
Breneman D, Breneman J, Dillow J, Swerdlow S,
Ballman E, Van Horn J, Steele P, Cualing H, Mutasim D, Barron D: Primary cutaneous CD30-positive large cell
lymphoma. American Academy of Dermatology
1993 annual meeting, Washington, D.C. 12/4-8/93.
Drake
L, Breneman D, Monroe E, Schupach C,
Halperin M: Topical doxepin hydrochloride
provides an increased clinical benefit when added to topical corticosteroid treatment for
atopic dermatitis. American Academy of
Dermatology 1993 annual meeting, Washington, D.C. 12/4-8/93.
Breneman DL,
Bronsky EA, Bruce S, Kalivas JT, Klein GL, Roth HL, Tharp MD, Treger C, Soter N: Cetirizine and astemizole in chronic idiopathic
urticaria: A double-blind placebo-controlled
comparative trial. American Academy of
Dermatology 1995 annual meeting, New Orleans, Louisiana 2/4-8/95.
Breneman DL, Montsinger MA, Van Horn JA, Cohen RM, Breneman JC: Transient gynecomastia as an adverse effect of
total skin electron beam irradiation for the treatment of cutaneous T-cell lymphoma. American Academy of Dermatology 1995 annual
meeting, New Orleans, Louisiana 2/4-8/95.
Pincus
S, Oseroff A, Breneman D, Foss F, Koh H,
Duvic M, Vonderheid E, Coe B, Phillips S, Bernstein J:
Effectiveness of topical naloxone HCl, 0.5%, in the treatment of pruritus
associated with mycosis fungoides and Sézary syndrome.
Society for Investigative Dermatology 1995 annual meeting, Chicago, Illinois
5/26/95.
Berberian
J, Breneman DL,
Hanifin JM, Drake LA, Gratton D, Raimer SS, Bernstein JE, Halperin M: Effects of adding topical doxepin to topical
corticosteroid therapy in atopic dermatitis. Society
for Investigative Dermatology 1995 annual meeting, Chicago, Illinois 5/26/95.
Pincus
S, Oseroff A, Breneman D, Foss F, Koh H,
Duvic M, Vonderheid E, Coe B, Phillips S, Bernstein J:
Effectiveness of topical naloxone HCl, 0.5%, in the treatment of pruritus
associated with mycosis fungoides and Sézary syndrome. American Academy of Dermatology
1995 summer meeting, Chicago, Illinois 7/22-29/95.
Breneman D, Duvic M, Kuzel T, Stevens V: Positive interim results in cutaneous T-cell
lymphoma. 14th Annual Hambrecht and Quist
Life Sciences Conference, San Francisco, California 1/8/96.
Sheth
P, Breneman D: Allergic contact dermatitis and stomatitis to
nickel-containing dental alloys. American
Academy of Dermatology annual meeting, Washington, D.C. 2/10-14/96.
Breneman D, Van Horn J, Breneman J: Cutaneous T-cell lymphoma: How much does it cost. American Academy of Dermatology annual meeting,
Washington, D.C. 2/10-14/96.
Breneman DL,
Duvic M, Kuzel T, Stevens V, Yocum R: Phase
1-2 clinical trial supports the safety and efficacy of Targretin topical gel, a novel
RXR-selective retinoid analogue, in the treatment of cutaneous T-cell lymphoma. American Society of Hematology annual meeting,
Orlando, Florida 12/9/96.
Breneman DL,
Berge CA, Keswick BH, Neumann PB: Evaluation
of the effect of an antibacterial bar soap on the clinical improvement, microbial skin
flora and the use of topical steroids in patients with atopic dermatitis. The Healthcare Continuum Model on Topical
Antimicrobial Wash Products in Healthcare Settings, the Food Industry, and the Home,
Washington, D.C. 6/2-3/97.
Scher
RK, Breneman D, Rich P, Savin R, Feingold
DS, Konnikov N: Pharmacokinetics and efficacy
of once-weekly fluconazole (150, 300, or 450 mg) in distal subungual onychomycosis of the
toenail. American Academy of Dermatology 1998
annual meeting, Orlando, Florida 2/27-3/3/98.
Breneman DL,
Berge CA, Keswick BH, Neumann PB: Evaluation
of the effect of an antibacterial bar soap with 1.5% TCC on the clinical improvement and
microbial skin flora in patients with atopic dermatitis.
American Academy of Dermatology annual meeting, Orlando, Florida
2/27-3/3/98.
Koo
J, Cuffie CA, Tanner DJ, Bressinck R, Cornell RC, DeVillez RL, Edwards L, Breneman DL,
Piacquadio DJ, Guzzo CA, Monroe EW: Mometasone
furoate 0.1%/salicylic acid 5% ointment twice daily versus mometasone furoate 0.1% twice
daily in the management of psoriasis. American
Academy of Dermatology annual meeting, Orlando, Florida 2/27-3/3/98.
Breneman DL,
Storer T, Breneman JC, Mutasim DF: Methotrexate-induced
cutaneous ulceration in patients with mycosis fungoides.
American Academy of Dermatology annual meeting, Orlando, Florida
2/27-3/3/98.
Breneman DL,
Raju US, Breneman JC, Steele PE, Swerdlow SH, Cualing HD:
LN grading for staging of mycosis fungoides may benefit from examination of
multiple excised lymph nodes. American
Academy of Dermatology annual meeting, Orlando, Florida 2/27-3/3/98.
Breneman DL,
Hakim MD: Comparative cost analysis of PUVA
and methotrexate in the treatment of psoriasis. American
Academy of Dermatology annual meeting, Orlando, Florida 2/27-3/3/98.
Breneman D, Bucko A, Friedman D, Maloney M, Rafal
E, Kang S, Tuley M, Dupre S, Plott T: Evaluation
of topical metronidazole lotion in rosacea. American
Academy of Dermatology annual meeting, Orlando, Florida 2/27-3/3/98.
Breneman D, Stewart D, Hevia O, Hino P, Drake L: A clinical efficacy trial of 1% metronidazole
cream administered once daily in the treatment of rosacea.
American Academy of Dermatology annual meeting, Orlando, Florida
2/27-3/3/98.
Breneman DL,
Van Horn JA, Breneman JC: Cutaneous T-cell
lymphoma patient support groups. American
Academy of Dermatology annual meeting, New Orleans, Louisiana, 3/19-23/99.
Breneman D, Duvic M, Kuzel T, Stevens V, Yocum R: Phase 1-2 clinical trial demonstrates the safety
and efficacy of bexarotene (LGD 1069) topical gel for the treatment of cutaneous T-cell
lymphoma. American Academy of Dermatology
annual meeting, New Orleans, Louisiana, 3/19-23/99.
Drake
L, Prendergast M, Maher RM, Breneman D,
Cooper K, Beausterien KM, Lawrence I. The
health-related quality-of-life impact of tacrolimus ointment for the treatment of atopic
dermatitis. American Academy of Dermatology
annual meeting, San Francisco, California 3/10-14/2000.
Duvic
M, Hymes K, Heald P, Breneman D, Matin A,
Myskowski P: Phase II-III clinical trial in
patients with refractory advanced stage CTCL demonstrates efficacy of safety of bexarotene
capsules. American Academy of Dermatology
annual meeting, San Francisco, California 3/10-14/2000.
Kuzel
T. Breneman D, Duvic M, Truglia J, Yocum R,
Stevens V: Phase I-II trial of bexarotene gel
in the topical treatment of patients with cutaneous T-Cell lymphoma. Society for Investigative Dermatology annual
meeting, Chicago, Illinois 5/10-14/2000.
Presentations
at Regional Meetings
Breneman DL: Skin and soft tissue infections. Houston Symposium Focus on Infection: 1988;
sponsored by the University of Texas and M.D. Anderson Hospital and Tumor Institute,
Houston, Texas 2/11/88.
Breneman DL: Skin and soft tissue infections. Dallas Symposium Focus on Infection: 1988;
sponsored by the University of Texas and M.D. Anderson Hospital and Tumor Institute,
Dallas, Texas 2/12/88.
Breneman DL: A randomized, double-blind study of Zostrix cream
(0.025% capsaicin) and Zostrix vehicle control in the treatment of moderate to severe
pruritus in patients undergoing chronic hemodialysis.
Ohio Dermatological Association 1988 annual meeting, Cincinnati, Ohio
9/17/88.
Breneman DL: Mycosis fungoides.
Ohio Dermatological Nurses Association 1988 annual meeting, Cincinnati, Ohio
9/17/88.
Breneman DL: Mycosis fungoides - aggressive versus conservative
therapeutic approaches. Ohio Dermatological
Association 1988 annual meeting, Cincinnati, Ohio 9/18/88.
Kauffman
RF, Breneman DL: Got an itch?
Ohio Dermatological Nurses Association 1989 annual meeting, Columbus, Ohio
9/23/89.
Ballman
EA, Breneman DL: Bath PUVA - what, when, and how? Ohio Dermatological Nurses Association 1989 annual
meeting, Columbus, Ohio 9/23/89.
Breneman DL: Mycosis fungoides - the clinical picture. Richard W. Vilter Cancer Symposium, Cincinnati,
Ohio 4/5/90.
Ballman
EA, Breneman DL: Mycosis fungoides.
Southwestern Tumor Registrar's Association, Cincinnati, Ohio 1/16/91.
Breneman DL: Mycosis fungoides - diagnosis, evaluation, and
management. Ohio Dermatological Nurses
Association 1991 annual meeting, Dayton, Ohio, 9/14/91.
Breneman DL: Mycosis fungoides - the clinical picture. Ohio Dermatological Association 1991 annual
meeting, Dayton, Ohio 9/15/91.
Cardone
JC, Breneman DL,
Mutasim DF, Fivenson DF: A randomized, open
label trial comparing the efficacy and safety of the combination of tetracycline and
nicotinamide in the treatment of bullous pemphigoid.
Ohio Dermatological Association 1991 annual meeting, Dayton, Ohio 9/15/91.
Breneman DL: Photoaging and photocarcinogenesis. Advances in Family Medicine Review Course,
Cincinnati, Ohio 5/7/93.
Breneman DL: Cutaneous lymphomas. University of Louisville Department of
Dermatology, Louisville, Kentucky 3/28/94.
Breneman DL: Cutaneous T-cell lymphomas other than mycosis
fungoides. Ohio Dermatological Association
1994 annual meeting, Columbus, Ohio 9/17/94.
Breneman DL: Cutaneous T-cell lymphoma update. Oncology Grand Rounds Kettering Medical Center,
Dayton, Ohio 6/1/2000.
Breneman DL: Cutaneous T-cell lymphoma update. Dermatology Grand Rounds Grandview Hospital,
Dayton, Ohio 6/2/2000.
Presentations
at Local Meetings
Dermatology
Basic Science, 11/83 - "Eccrine Glands"
Dermatology
Basic Science, 3/84 - "Apocrine Glands"
Dermatology
Basic Science, 6/84 - "The Porphyrias"
Dermatology
Basic Science, 2/85 - "Porphyria Cutanea Tarda"
Greater
Cincinnati Society of Radiation Therapy Technologists, 6/86 - "Skin Cancer"
Oncology
Nursing Certification Review Course, 2/87 - "Skin Malignancies"
Dermatology
Basic Science, 4/87 - "Clinical Research Studies"
Dermatology
Grand Rounds, 11/87 - "Bath PUVA"
Dermatology
Basic Science, 3/88 - "Mupirocin for Secondarily Infected Dermatoses"
Oncology
Nursing Certification Review Course, 3/88 - "Skin Malignancies"
Dermatology
Grand Rounds, 8/88 - "Common Cutaneous Infections"
Clinical
Toxicology Journal Club, 10/88 - "Retinoids in Dermatology"
Dermatology
Grand Rounds, 12/88 - "Bath PUVA"
American
Cancer Society Professional Education Nursing Seminar, 5/89 - "Skin Cancer"
Dermatology
Grand Rounds, 7/89 - "Common Cutaneous Infections"
Oncology
Nursing Certification Review Course, 1/90 - "Skin Malignancies"
Dermatology
Grand Rounds, 1/90 - "Update on Mycosis Fungoides"
Dermatology
Basic Science, 2/90 - "Mycology I - Saprophytic Fungi"
Dermatology
Basic Science, 5/90 - "Mycology II - Dermatophytes"
Dermatology
Basic Science, 6/90 - "Mycology III - Dimorphic Fungi and Yeasts"
Oncology
Nursing Certification Review Course, 3/91 - "Skin Malignancies"
Dermatology
Grand Rounds, 5/91 - "Update on Bath PUVA"
Dermatology
Basic Science, 7/91 - "Dermatophytes"
Dermatology
Grand Rounds, 10/91 - "Mycosis Fungoides - Clinical Evaluation and Current
Research"
Dermatology
Basic Science, 1/92 - "The Zygomycetes, Dematiaceous Molds, and Rapidly Growing
Hyaline Molds"
Oncology
Nursing Certification Review Course, 4/92 - "Skin Malignancies"
Medical
Student Skin Club, 5/92 - "The Sun and Your Skin"
Dermatology
Grand Rounds, 7/92 - "Research Presentations"
Dermatology
Grand Rounds, 3/93 - "Cutaneous Lymphomas - Unusual
Presentations"
Oncology
Nursing Certification Review Course, 4/93 -
"Skin Malignancies"
Dermatology
Grand Rounds, 7/93 - "Cutaneous Lymphomas other than
Mycosis Fungoides"
Dermatology
Basic Science, 3/94 - "Dermatophytes"
Dermatology
Basic Science, 4/94 - "Dimorphic Fungi"
Dermatology
Basic Science, 5/94 - "Saprophytic Fungi"
Dermatology
Grand Rounds, 6/94 - "Cutaneous T-Cell Lymphoma - Therapeutic Challenge"
Dermatology
Grand Rounds, 11/94 - "Cost and Therapeutic Outcome in Cutaneous T-Cell
Lymphoma"
Dermatology
Grand Rounds, 3/96 - "Topical Anti-Pruritic Update"
Dermatology
Basic Science, 3/96 - "The Zygomycetes, Dematiaceous Molds, and Rapidly Growing
Hyaline Molds"
Dermatology
Basic Science, 3/96 - "Dermatophytes"
Dermatology
Basic Science, 4/96 - "Dimorphic Fungi"
Dermatology
Grand Rounds, 6/96 - "Urticaria"
Radiation
Oncology Grand Rounds, 9/96 - "The Cutaneous T-Cell Lymphomas"
Dermatology
Grand Rounds, 10/96 - "Evaluation of Cutaneous T-Cell
Lymphomas"
Dermatology
Grand Rounds, 4/97 - "Phase 1-2 Clinical Trial Supports the Safety and Efficacy of
Targretin Topical Gel in the Treatment of Cutaneous T- Cell Lymphoma"
Dermatology
Grand Rounds, 5/98 - "Cutaneous T-Cell Lymphoma: Support Groups and the
Internet"
Dermatology
Grand Rounds, 9/99 - "Update on Cutaneous T-Cell Lymphoma"
Cincinnati
Oncology Group, 3/2000 - "New Treatments for Cutaneous T-Cell Lymphoma"
Dermatology
Grand Rounds, 5/2000 - "New Treatments for Cutaneous T-Cell Lymphoma"
Moderator
at Professional Meetings
Residents'
Forum, Ohio Dermatological Association 1991 annual meeting, Dayton, Ohio 9/15/91.
CLICK HERE TO RETURN TO MAIN MENU
CLICK HERE TO RETURN TO CLINICAL
RESEARCH
